Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN||- / UNK||- / -|
Administered by: Other Purchased by: ??
Symptoms: Dysarthria, Mouth swelling
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Current Illness: Abstains from alcohol; Non-smoker
Preexisting Conditions: Comments: No abuse or illicit drug usage
Diagnostic Lab Data:
CDC 'Split Type': USJNJFOC20210728488
Write-up: SWOLLEN LIPS AND TONGUE; SLURRED SPEECH; This spontaneous report received from a patient concerned a 67 year old female. The patient''s weight was 140 pounds, and height was 67 inches. The patient''s concurrent conditions included non-smoker, and non-alcohol user, and other pre-existing medical conditions included no abuse or illicit drug usage. The patient experienced anaphylactic reaction to morphine and drug allergy when treated with morphine, drug allergy when treated with codeine, lisinopril, hydrocodone bitartrate/paracetamol, and tramadol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: 07-AUG-2021) dose was not reported, administered on 12-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On JUL-2021, the subject experienced slurred speech. On 12-JUL-2021, the subject experienced swollen lips and tongue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slurred speech on JUL-2021, and was recovering from swollen lips and tongue. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166